4-butyrolactone has been researched along with Inflammatory Bowel Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, J; Fang, S; Huang, Y; Li, M; Luo, Y; Mei, Y; Pan, H; Wan, T; Wang, Q; Wang, Z; Xue, J; Zhang, Y | 1 |
| Back, SY; Bae, MJ; Choi, SW; Do, JR; Jung, SY; Kim, YT; See, HJ; Shin, HS; Shon, DH | 1 |
2 other study(ies) available for 4-butyrolactone and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARĪ³-mediated inflammation pathways.
Topics: 4-Butyrolactone; Animals; Biological Products; Colitis; Colon; Cytokines; Dextran Sulfate; Female; Inflammation; Inflammation Mediators; Inflammatory Bowel Diseases; Mice, Inbred C57BL; Models, Biological; Network Pharmacology; NF-kappa B; PPAR gamma; Signal Transduction; Transcription Factor AP-1 | 2021 |
Enhancing Effect of Trachelogenin from Trachelospermi caulis Extract on Intestinal Barrier Function.
Topics: 4-Butyrolactone; Allergens; Apocynaceae; Caco-2 Cells; Colon; Food Hypersensitivity; Glucosides; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Occludin; Ovalbumin; Permeability; Phytotherapy; Plant Extracts; Tight Junctions | 2015 |